Directory
Javier Gómez Arbonés

Javier Gómez Arbonés

Degree: PhD

973 702 208
xavier.gomez(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/C-1212-2009

Publications

  • Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; Gómez CT; Garí E; Aguayo-Ortiz RS

    Biomarkers found in the tumor interstitial fluid may help explain the differential behavior among keratinocyte carcinomas.

    MOLECULAR & CELLULAR PROTEOMICS 22 100547-100547. .

    [doi:10.1016/j.mcpro.2023.100547]

  • Fuertes Abardía C; Ballesta Juan P; Cruz Esteve I; Galindo Ortego G; Marsal Mora JR; Gómez-Arbonés X

    Prescripción potencialmente inadecuada: utilidad de los criterios STOPP/START versión 2 a nivel poblacional en Cataluña.

    MEDICINA DE FAMILIA-SEMERGEN 48 163-173. .

    [doi:10.1016/j.semerg.2021.09.005]

  • Matas-Nadal, C; Sagrista, M; Gomez-Arbones, X; Sobrino Bermejo C; Fernandez-Armenteros, JM; Àngel Baldó J; Casanova Seuma JM; Aguayo Ortiz R

    Risk factors for early-onset basal cell carcinomas and the trend towards their female predominance.

    Journal Der Deutschen Dermatologischen Gesellschaft 19 364-371. .

    [doi:10.1111/ddg.14390]

  • Matas-Nadal C; Sagristà M; Gómez-Arbonés X; Sobrino Bermejo C; Fernández-Armenteros JM; Àngel Baldó J; Casanova Seuma JM; Aguayo Ortiz R

    Risikofaktoren für Basalzellkarzinome in jungem Alter und Trend zur Prädominanz bei Frauen.

    Journal Der Deutschen Dermatologischen Gesellschaft 19 364-372. .

    [doi:10.1111/ddg.14390_g]

  • Bellés-Bellés A; Bernal M; Gómez-Arbonés J; Bernet A; Picó S; Bueno J; Chávez C; García-González M; Ibarz M

    E-gene RT-PCR Crossing Point Value and Other Biochemical Parameters as Useful Markers of Death Risk in COVID-19 Patients.

    ejournal International Federation of Clinical Chemistry and Laboratory Medicine 32 98-104. .

  • Lopez-Cano, C; Gutierrez-Carrasquilla, L; Sanchez, E; Gonzalez, J; Yeramian, A; Marti, R; Hernandez, M; Cao, G; Ribelles, M; Gomez, X; Barril, S; Barbe, F; Hernandez, C; Simo, R; Lecube, A

    Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes

    Frontiers in Endocrinology 10 752-752. .

    [doi:10.3389/fendo.2019.00752]

  • Revuelto Artigas T; Zaragoza Velasco N; Gómez Arbones X; Vidal Ballester T; Piñol Felis C; Reñe Espinet JM; Betriu Bars A

    Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis

    REVISTA CLINICA ESPANOLA 219 293-302. .

    [doi:10.1016/j.rce.2018.12.007]

  • Fernandez-Armenteros, JM; Gomez-Arbones, X; Buti-Sole, M; Betriu-Bars, A; Sanmartin-Novell, V; Ortega-Bravo, M; Martinez-Alonso, M; Casanova-Seuma, JM

    Epidemiology of Psoriasis. A Population-Based Study.

    Actas Dermo-Sifiliograficas 110 385-392. .

    [doi:10.1016/j.ad.2018.10.015]

  • Revuelto Artigas T; Betriu Bars À; Zaragoza Velasco N; Gómez Arbones X; Vidal Ballester T; Piñol Felis C; Reñé Espinet JM

    Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis c virus

    GASTROENTEROLOGIA Y HEPATOLOGIA 42 362-371. .

    [doi:10.1016/j.gastrohep.2019.02.002]

  • Fernandez-Armenteros, JM; Gomez-Arbones, X; Buti-Soler, M; Betriu-Bars, A; Sanmartin-Novell, V; Ortega-Bravo, M; Martinez-Alonso, M; Gari, E; Portero-Otin, M; Santamaria-Babi, L; Casanova-Seuma, JM

    Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 33 128-135. .

    [doi:10.1111/jdv.15159]

  • Fernández-Armenteros J.M.; Gómez-Arbonés X.; Buti-Solé M.; Betriu-Bars A.; Sanmartin-Novell V.; Ortega-Bravo M.; Martínez-Alonso M.; Casanova-Seuma J.M.

    Epidemiology of Psoriasis. A Population-Based Study

    ACTAS DERMO-SIFILIOGRAFICAS -. .

    [doi:10.1016/j.adengl.2019.01.014]

  • Lecube, A.; Sanchez, E.; Lopez-Cano, C.; Sanchez, M.; Gaeta, A.; Purroy, F.; Pamplona, R.; Ortega, M.; Vidal, T.; Betriu, A.; Gomez, X.; Hernandez, M.; Olsina, J.; Hernandez, C.; Simo, R.

    Pulmonary function in prediabetes: dysfunction appears before the development of type 2 diabetes

    Diabetologia 61 512-512. .

Projects

  • Development of a simulation environment as a tool to support the design of studies and clinical trials.
  • Diabetes mellitus tipo 2 y activación simpática durante el sueño